Stockscreener 앱 받기
2.27
2.58%
-0.06
시간 외 거래:
2.32
0.05
+2.20%
전일 마감가:
$2.33
열려 있는:
$2.29
하루 거래량:
280.60K
Relative Volume:
0.32
시가총액:
$241.57M
수익:
$45.44M
순이익/손실:
$-35.43M
주가수익비율:
-6.6765
EPS:
-0.34
순현금흐름:
$-25.39M
1주 성능:
+5.58%
1개월 성능:
+2.48%
6개월 성능:
-51.29%
1년 성능:
-48.64%
1일 변동 폭
$2.24
$2.33
1주일 범위
$2.02
$2.37
52주 변동 폭
$2.00
$5.20
맥스사이트 Stock (MXCT) Company Profile
명칭
Maxcyte Inc
전화
301-517-5556
주소
9713 KEY WEST AVENUE,, ROCKVILLE
MXCT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MXCT
Maxcyte Inc
|
2.27 | 238.15M | 45.44M | -35.43M | -25.39M | -0.34 |
|
ABT
Abbott Laboratories
|
125.64 | 218.92B | 43.11B | 13.98B | 6.66B | 7.98 |
|
BSX
Boston Scientific Corp
|
106.21 | 152.62B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
396.66 | 153.22B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
92.32 | 117.89B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
75.80 | 45.12B | 5.54B | 4.18B | 623.10M | 7.00 |
맥스사이트 Stock (MXCT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-22 | 개시 | Stephens | Overweight |
| 2023-11-29 | 개시 | Craig Hallum | Buy |
| 2021-10-15 | 재개 | Cowen | Outperform |
| 2021-08-24 | 개시 | BTIG Research | Buy |
| 2021-08-24 | 개시 | Cowen | Outperform |
| 2021-08-24 | 개시 | Stephens | Overweight |
| 2021-08-24 | 개시 | Stifel | Buy |
| 2021-08-24 | 개시 | Wedbush | Outperform |
| 2021-08-24 | 개시 | William Blair | Outperform |
모두보기
맥스사이트 주식(MXCT)의 최신 뉴스
Is MaxCyte Inc. a good long term investmentHigh-return market picks - PrintWeekIndia
What makes MaxCyte Inc. stock attractive to long term investorsExceptional stock performance - jammulinksnews.com
What analysts say about MaxCyte Inc. stockRapid portfolio appreciation - Autocar Professional
MaxCyte Inc. Stock Analysis and ForecastSuperior risk-adjusted returns - Autocar Professional
Published on: 2025-07-23 21:52:41 - Autocar Professional
What drives MaxCyte Inc. stock priceFree Technical Analysis Support - Autocar Professional
Why MaxCyte Inc. stock attracts strong analyst attentionHigh Potential Stock Ideas - Newser
What makes MaxCyte Inc. stock price move sharplySwing Trade Signals - Newser
IWN ETF Implied Analyst Target Price: $198.15 - AInvest
How MaxCyte Inc. stock performs during market volatilityDaily Swing Candidates - Newser
MaxCyte to Report Second Quarter 2025 Financial Results on August 6, 2025 - The Manila Times
MaxCyte, Inc. to Release Second Quarter 2025 Financial Results on August 6th - Nasdaq
PHC announces exclusive distribution of MaxCyte ExPERT platform in Japan - BioSpectrum Asia
PHC TO EXCLUSIVELY DISTRIBUTE MAXCYTE CELL ENGINEERING PLATFORM IN JAPAN - bernama
Business Wire - JIJI PRESS
PHC Announces Exclusive Distribution of MaxCyte® ExPERT™ Platform in Japan - Business Wire
MaxCyte Cancels AIM Market Trading for Common Stock - TipRanks
MaxCyte shares trading for last time in London - Sharecast.com
Moving Gene Editing Advances Into the Clinic - the-scientist.com
MaxCyte stockholders approve AIM delisting, company to trade only on Nasdaq - Investing.com
MaxCyte Shareholders Approve Equity Plan Amendment - TipRanks
MaxCyte shareholders approve equity plan expansion, AIM delisting - Investing.com
Analyzing Ratios: MaxCyte Inc (MXCT)’s Financial Story Unveiled - DWinneX
MaxCyte shareholders approve equity plan expansion, AIM delisting By Investing.com - Investing.com UK
California State Teachers Retirement System Sells 82,134 Shares of MaxCyte, Inc. (NASDAQ:MXCT) - Defense World
MaxCyte Announces Change in Major Holdings by BlackRock - TipRanks
맥스사이트 (MXCT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.03%
0.79%
자본화:
|
볼륨(24시간):